0001475030-17-000002.txt : 20170724 0001475030-17-000002.hdr.sgml : 20170724 20170724153832 ACCESSION NUMBER: 0001475030-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170724 DATE AS OF CHANGE: 20170724 EFFECTIVENESS DATE: 20170724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tarsa Therapeutics, Inc. CENTRAL INDEX KEY: 0001475030 IRS NUMBER: 264828302 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-291370 FILM NUMBER: 17978284 BUSINESS ADDRESS: STREET 1: 8 PENN CENTER CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 267-273-7940 MAIL ADDRESS: STREET 1: 8 PENN CENTER CITY: PHILADELPHIA STATE: PA ZIP: 19103 D 1 primary_doc.xml X0708 D LIVE 0001475030 Tarsa Therapeutics, Inc. 8 PENN CENTER 1628 JFK Blvd. Suite 1400 PHILADELPHIA PA PENNSYLVANIA 19103 267-273-7940 DELAWARE None None Corporation true David Brand 8 Penn Center, 1628 JFK Blvd. Suite 1400 c/o Tarsa Therapeutics, Inc. Philadelphia PA PENNSYLVANIA 19103 Executive Officer Director Gregory Lumpkin 8 Penn Center, 1628 JFK Blvd. Suite 1400 c/o Tarsa Therapeutics, Inc. Philadelphia PA PENNSYLVANIA 19103 Executive Officer Eric Bednarski 8 Penn Center, 1628 JFK Blvd. Suite 1400 c/oTarsa Therapeutics, Inc. Philadelphia PA PENNSYLVANIA 19103 Director Martin Edwards 8 Penn Center, 1628 JFK Blvd. Suite 1400 c/o Tarsa Therapeutics, Inc. Philadelphia PA PENNSYLVANIA 19103 Director Richard Kollender 8 Penn Center, 1628 JFK Blvd. Suite 1400 c/o Tarsa Therapeutics, Inc. Philadelphia PA PENNSYLVANIA 19103 Director Richard Levy 8 Penn Center, 1628 JFK Blvd. Suite 1400 c/o Tarsa Therapeutics, Inc. Phildelphia PA PENNSYLVANIA 19103 Director Biotechnology Decline to Disclose 06b false 2017-07-07 false true true false 0 1000000 549858 450142 false 3 0 0 0 false Tarsa Therapeutics, Inc. David Brand David Brand President & CEO 2017-07-24